Role of cholecystokinin receptor in hepatocellular cancer
Project Number5K01CA255572-04
Former Number1K01CA255572-01
Contact PI/Project LeaderGAY, MARTHA
Awardee OrganizationGEORGETOWN UNIVERSITY
Description
Abstract Text
Project Summary/ Abstract
Background: The cholecystokinin (CCK) receptor is a G-protein coupled receptor that regulates physiologic
gastrointestinal digestive functions and growth of the gastrointestinal tract. CCK receptors become
overexpressed in gastrointestinal cancers where receptor activation by the ligands, CCK on or gastrin,
stimulate cancer growth and metastases. CCK receptors have also been described as fibroblasts. When
activated, these cells produce collagen-associated proteins that lead to fibrosis associated with malignancies
and are thought to impede the penetration of therapeutic agents.
Innovation: We recently showed that a diet high in saturated fat induces the expression of hepatic CCK- B
receptors in a murine model of nonalcoholic steatohepatitis. The CCK receptor antagonist, proglumide,
reversed inflammation, fibrosis, and steatosis prevented the development of hepatocellular carcinoma in the
murine NASH model.
Long-term objectives: In this proposal, I plan to investigate the mechanisms of how CCK receptors mediate
hepatic inflammation and fibrosis and the role of CCK receptors in hepatocellular cancer.
Research Aims: In vitro studies will be performed to analyze the potential of cross-talk between CCK
receptors and chemokine receptors. The role of CCK receptors in regulating hepatic fibrosis in stellate cells will
be carried out in vitro using CRISPR technology to selectively knockout cancer cell CCK receptors and in vivo
with transgenic mice engineered to be null in the CCK-B receptor. Lastly, we will examine the novel idea of
whether liver injury and NASH induce proliferation of hepatic stem cells that express CCK-B receptors and
these stem cells are responsible for HCC.
Candidate's Goals: Are to understand the pathophysiology of CCK receptors in liver cancer development and
progression. This proposal will be completed under the guidance of an experienced mentor team that includes
accomplished tumor biologists, immunologists, and hepatology cancer researchers. To accomplish these
goals, the candidate will work with her mentors and constantly review research objectives for publication to
address candidate’s publication record and the Professional Development Office to follow a career
development plan by incorporating diverse methodologies for advancement, which includes manuscript
preparation, project management adhering to timelines, effectively managing a budget, attending and
presenting at national conferences and departmental seminars, mentoring graduate and undergraduate
students, and preparing application materials.
Public Health Relevance Statement
Project Narrative
The overall purpose of this project is to understand the mechanism by which the cholecystokinin (CCK) B-
receptor is activated in liver injury and NASH and how this activation increases the risk for hepatocellular
cancer (HCC). Epigenetic regulation of the CCK receptor will be studied and cross-talk with chemokine
receptors. Several murine models of liver injury and a transgenic CCK-BR-knockout mouse model will be used
to investigate whether stem cells or liver progenitor cells express the CCK-BR and if a CCK-receptor
antagonist can decrease the risk of HCC.
No Sub Projects information available for 5K01CA255572-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01CA255572-04
Patents
No Patents information available for 5K01CA255572-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01CA255572-04
Clinical Studies
No Clinical Studies information available for 5K01CA255572-04
News and More
Related News Releases
No news release information available for 5K01CA255572-04
History
No Historical information available for 5K01CA255572-04
Similar Projects
No Similar Projects information available for 5K01CA255572-04